VIRION THERAPEUTICS
Virion Therapeutics is a science-driven company developing innovative immune-based treatments for virally associated cancers and chronic viral infections. Their vaccines, ChiVax and ChiVax-gD, represent novel and highly effective platforms to induce potently and sustained T cell-mediated immune responses against transformed or infected cells, thereby targets common diseases with unmet medical needs. Each component comprising chimeric vaccine candidates has completed pre-clinical testing that all... ows for their translation into clinical trials for several different indications. Guided by their scientific and management expertise, these platforms may help cure such devastating diseases as HPV-induced cancers and chronic Hepatitis B infections. Virion Therapeutics was founded in 2018 and is headquartered in Newark, Delaware.
VIRION THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2018-01-01
Address:
Newark, Delaware, United States
Country:
United States
Website Url:
http://www.viriontx.com
Total Employee:
11+
Status:
Active
Contact:
800-841-9303
Email Addresses:
[email protected]
Total Funding:
14.08 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics LetsEncrypt SSL By Default
Similar Organizations
Alethia BioTherapeutics
Alethia BioTherapeutics is a biotechnology company developing monoclonal antibody-based therapeutics for cancer-associated diseases.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Current Employees Featured
Founder
Investors List
Puget Sound Venture Club
Puget Sound Venture Club investment in Venture Round - Virion Therapeutics
Keiretsu Capital
Keiretsu Capital investment in Convertible Note - Virion Therapeutics
Robin Hood Ventures
Robin Hood Ventures investment in Convertible Note - Virion Therapeutics
Mid Atlantic Bio Angels
Mid Atlantic Bio Angels investment in Series A - Virion Therapeutics
Keiretsu Forum
Keiretsu Forum investment in Series A - Virion Therapeutics
Crimson Peak
Crimson Peak investment in Series A - Virion Therapeutics
Robin Hood Ventures
Robin Hood Ventures investment in Series A - Virion Therapeutics
Keiretsu Capital
Keiretsu Capital investment in Series A - Virion Therapeutics
Alliance of Angels
Alliance of Angels investment in Series A - Virion Therapeutics
Life Science Angels
Life Science Angels investment in Series A - Virion Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-11-22 | Virion Therapeutics, LLC Announces the Appointment of Sue Currie, Ph.D. as Chief Operating Officer |
Official Site Inspections
http://www.viriontx.com Semrush global rank: 13.91 M Semrush visits lastest month: 67
- Host name: 162.60.66.34.bc.googleusercontent.com
- IP address: 34.66.60.162
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Virion Therapeutics"
Virion Therapeutics – T cell Based Immunotherapies for Cancer …
Virion Therapeutics is a clinical-stage company developing novel T cell-based immunotherapies for cancer and chronic infectious diseases. We utilize genetically encoded checkpoint …See details»
About – Virion Therapeutics
Driven by science, our mission is to revolutionize the immunotherapy treatment landscape, focusing on the development of novel, adaptable, and accessible CD8 + T cell-based technologies.See details»
Virion Therapeutics, LLC | LinkedIn
Virion is at the forefront of developing novel T cell-based immunotherapies designed to enhance and broaden CD8+ T cell responses against tumors and chronic infections, including their lead...See details»
Science – Virion Therapeutics
Through intelligent and science-driven processes, we give our T-cell based immunotherapies the best chance to succeed and achieve our vision of transforming the treatment landscape for …See details»
Virion Therapeutics - Crunchbase Company Profile & Funding
Virion Therapeutics is a science-driven company developing innovative immune-based treatments for virally-associated cancers. View contacts for Virion Therapeutics to access new leads and …See details»
Virion Therapeutics Reports Positive First-in-human, First-in-class ...
Jun 5, 2024 · Virion Therapeutics, LLC is a clinical-stage company developing novel T cell-based immunotherapies to cure cancer and chronic infectious diseases that utilize proprietary …See details»
Virion Therapeutics, LLC Announces the Appointment of Sue …
Philadelphia PA, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Virion Therapeutics, LLC, developer of immunotherapies for cancer and chronic infectious diseases that utilize genetically encoded …See details»
Virion Therapeutics Presents Promising Preclinical Cancer Data …
Mar 6, 2023 · Virion Therapeutics, LLC, is a science driven company whose mission is to cure cancer and chronic infectious diseases through the development of novel and accessible CD8 …See details»
Virion Therapeutics, LLC Raises $5 Million to Develop Checkpoint ...
Sep 26, 2018 · Virion Therapeutics, LLC, is a science driven company developing innovative immune-based treatments for virally associated cancers and chronic viral infections utilizing …See details»
Virion Therapeutics Company Profile 2024: Valuation, Funding ...
Developer of novel immunotherapies designed to treat cancers and infectious diseases. The company's immunotherapies use targeted novel T-cell-based therapies that couple a …See details»
Virion Therapeutics Presents Promising Preclinical Cancer
Mar 6, 2023 · Virion Therapeutics, LLC presented data today of a genetically encoded checkpoint modifier-based immunotherapy, which enhances CD8+ T cell activation, in a fast-growing …See details»
Virion Therapeutics - Overview, News & Similar companies
Virion Therapeutics contact info: Phone number: (800) 841-9303 Website: www.viriontx.com What does Virion Therapeutics do? Virion Therapeutics, LLC, is a science driven company …See details»
Virion Therapeutics, LLC Raises $5 Million to Develop Checkpoint ...
Sep 26, 2018 · Virion Therapeutics, LLC, is a science driven company developing innovative immune-based treatments for virally associated cancers and chronic viral infections utilizing …See details»
Andrew Luber – Virion Therapeutics
Dr. Andrew D. Luber serves as President and Chief Executive Officer for Virion Therapeutics, LLC. He is one of the founders of Virion Therapeutics, LLC and has been successfully …See details»
Virion Therapeutics - VentureRadar
Website: https://www.viriontx.com/ Develops novel T cell-based immunotherapies for cancer and infectious diseases via genetically encoded checkpoint inhibitor, targeting Hepatitis B and …See details»
Virion Therapeutics Presents Promising Preclinical Cancer Data …
Mar 6, 2023 · Virion Therapeutics, LLC, is a science driven company whose mission is to cure cancer and chronic infectious diseases through the development of novel and accessible CD8 …See details»
Virion Therapeutics and Joint Venture Partner, Ocean Biomedical …
Oct 26, 2023 · Virion Therapeutics, LLC is a clinical-stage company developing novel T cell-based immunotherapies to cure cancer and chronic infectious diseases that utilize proprietary …See details»
News – Virion Therapeutics
Nov 19, 2024 · 06/05/2024. Virion Therapeutics Reports Positive First-in-human, First-in-class, Phase 1b Immunogenicity Data of VRON-0200, a Novel Checkpoint Modifier for HBV …See details»
Recommended Stories - Yahoo Finance
Jun 25, 2021 · VRON-0200 is a therapeutic vaccine being developed for chronic HBV infections that uses key HBV antigens that are conserved between multiple viral genotypes and …See details»
Pipeline – Virion Therapeutics
Jan 1, 2022 · VRON-0200 is designed to address a global high unmet medical need for chronic HBV infection. VRON-0200 combines a genetically encoded checkpoint modifier along with …See details»